Veronica Galvan Hart

Citée par

	Toutes	Depuis 2020
Citations	9877	4388
indice h	52	36
indice i10	78	59

940

470

235

705

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202536 46 66 100 70 97 134 171 207 244 291 337 377 435 390 406 453 462 472 604 650 824 904 931 935 139

Accès public

Tout afficher

59 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Dale BredesenBuck Institute for Research on AgingAdresse e-mail validée de buckinstitute.org
Arlan RichardsonUniversity of OklahomaAdresse e-mail validée de ouhsc.edu
Stacy A HussongUniversity of Oklahoma Health Sciences Center and Oklahoma City Veterans Health Care SystemAdresse e-mail validée de ouhsc.edu
K JinUniversity of PlymouthAdresse e-mail validée de royal.ac.cn
Zoltan Ungvari, M.D., Ph.D.Vascular Cognitive Impairment & Neurodegeneration Program OUHSCAdresse e-mail validée de ouhsc.edu
Candice E. Van SkikeResearch Instructor, Barshop Institute for Longevity and Aging Studies, UT Health San AntonioAdresse e-mail validée de uthscsa.edu
Randy StrongProfessor of Pharmacology, UT Health San AntonioAdresse e-mail validée de uthscsa.edu
Natalia PodlutskayaUniversity of Alaska FairbanksAdresse e-mail validée de alaska.edu
Stefano Tarantini, Ph.D.University of Oklahoma Health Sciences Center - Department of NeurosurgeryAdresse e-mail validée de ouhsc.edu
Ai-Ling LinProfessor and Vice Chair for Research of Radiology, University of Missouri-ColumbiaAdresse e-mail validée de health.missouri.edu
Andriy YabluchanskiyUniversity of Oklahoma HSCAdresse e-mail validée de ouhsc.edu
Bernard RoizmanProfessor of Virology University of ChicagoAdresse e-mail validée de bsd.uchicago.edu
Juan BeauquisInstituto de Biología y Medicina Experimental, CONICETAdresse e-mail validée de qb.fcen.uba.ar
Tamas KissSemmelweis UniversityAdresse e-mail validée de semmelweis.hu
Victoria DelpinoINIGEMAdresse e-mail validée de ffyb.uba.ar
S AustadUniversity of Alabama at BirminghamAdresse e-mail validée de uab.edu
Jayanta DebnathDistinguished Professor and Chair of Pathology, University of California San FranciscoAdresse e-mail validée de ucsf.edu
Peter T. FoxResearch Imaging Institute, University of Texas Health Science Center at San AntonioAdresse e-mail validée de uthscsa.edu
Daniel C. LuUCLAAdresse e-mail validée de mednet.ucla.edu
Rakez KayedutmbAdresse e-mail validée de utmb.edu

Suivre

Veronica Galvan Hart

University of Oklahoma Health Sciences Center

Adresse e-mail validée de ouhsc.edu - Page d'accueil

Neurobiology/ Alzheimer's/ Aging


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer's disease P Spilman, N Podlutskaya, MJ Hart, J Debnath, O Gorostiza, D Bredesen, ... PloS one 5 (4), e9979, 2010	1178	2010
Mechanisms of vascular aging Z Ungvari, S Tarantini, AJ Donato, V Galvan, A Csiszar Circulation research 123 (7), 849-867, 2018	800	2018
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice K Jin, V Galvan, L Xie, XO Mao, OF Gorostiza, DE Bredesen, ... Proceedings of the National Academy of Sciences 101 (36), 13363-13367, 2004	613	2004
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 V Galvan, OF Gorostiza, S Banwait, M Ataie, AV Logvinova, S Sitaraman, ... Proceedings of the National Academy of Sciences 103 (18), 7130-7135, 2006	302	2006
Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner V Galvan, B Roizman Proceedings of the National Academy of Sciences 95 (7), 3931-3936, 1998	296	1998
Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease J Beauquis, P Pavía, C Pomilio, A Vinuesa, N Podlutskaya, V Galvan, ... Experimental Neurology 239, 28-37, 2013	252	2013
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer’s disease AL Lin, W Zheng, JJ Halloran, RR Burbank, SA Hussong, MJ Hart, ... Journal of Cerebral Blood Flow & Metabolism 33 (9), 1412-1421, 2013	236	2013
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice J Halloran, SA Hussong, R Burbank, N Podlutskaya, KE Fischer, ... Neuroscience 223, 102-113, 2012	232	2012
In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β-peptide of APP DA Butterfield, V Galvan, MB Lange, H Tang, RA Sowell, P Spilman, ... Free Radical Biology and Medicine 48 (1), 136-144, 2010	221	2010
Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats K Jin, XO Mao, L Xie, V Galvan, B Lai, Y Wang, O Gorostiza, X Wang, ... Journal of Cerebral Blood Flow & Metabolism 30 (3), 534-544, 2010	219	2010
Effect of rapamycin on aging and age-related diseases—past and future R Selvarani, S Mohammed, A Richardson Geroscience 43, 1135-1158, 2021	207	2021
Glycoprotein D or J Delivered in transBlocks Apoptosis in SK-N-SH Cells Induced by a Herpes Simplex Virus 1 Mutant Lacking Intact Genes Expressing Both … G Zhou, V Galvan, G Campadelli-Fiume, B Roizman Journal of virology 74 (24), 11782-11791, 2000	205	2000
Rapamycin and Alzheimer’s disease: time for a clinical trial? M Kaeberlein, V Galvan Science translational medicine 11 (476), eaar4289, 2019	164	2019
Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP MJ Saganich, BE Schroeder, V Galvan, DE Bredesen, EH Koo, ... Journal of Neuroscience 26 (52), 13428-13436, 2006	163	2006
Polyphosphate: a conserved modifier of amyloidogenic processes CM Cremers, D Knoefler, S Gates, N Martin, JU Dahl, J Lempart, L Xie, ... Molecular cell 63 (5), 768-780, 2016	161	2016
Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease AL Lin, JB Jahrling, W Zhang, N DeRosa, V Bakshi, P Romero, V Galvan, ... Journal of Cerebral Blood Flow & Metabolism 37 (1), 217-226, 2017	157	2017
Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624) GM Shaked, MP Kummer, DC Lu, V Galvan, DE Bredesen, EH Koo The FASEB journal: official publication of the Federation of American …, 2006	155	2006
Neurogenesis in the aging brain V Galvan, K Jin Clinical interventions in aging 2 (4), 605-610, 2007	154	2007
Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain DL Vogt, D Thomas, V Galvan, DE Bredesen, BT Lamb, SW Pimplikar Neurobiology of aging 32 (9), 1725-1729, 2011	147	2011
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story A Richardson, V Galvan, AL Lin, S Oddo Experimental gerontology 68, 51-58, 2015	135	2015

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs